The special, discounted room rate available for early registrants of the second MidWest Drug Development Conference expires this Friday, Aug. 30.
A link to the discounted room rate can be found by clicking the “Venue” tab on the conference website (https://www.mwdrugdevelopment.com).
Friday also marks the 30-day mark for the conference, which begins on Monday, Sept. 30. The conference concludes the following day, Tuesday, Oct. 1. It will be held at the Capital District Marriott in downtown Omaha.
The event will feature top therapeutic technologies from each participating institution. All told, about 50 therapeutic technologies will be highlighted during 10-minute presentations at the two-day conference. Another key feature of the conference are the one-on-one partnering meetings that build new relationships between academic researchers and industrial partners or venture capital groups.
Included among the participants are such notable medical research institutions as Cincinnati Children’s Hospital, Kansas State University, Mayo Clinic, Ohio State University, Purdue University, University of Colorado Anschutz Medical Campus, University of Iowa, University of Kansas, University of Kentucky, University of Missouri, University of Missouri-Kansas City, University of Nebraska Medical Center, University of Notre Dame, University of Oklahoma, University of South Dakota, University of Toledo and the Wisconsin Alumni Research Foundation or WARF.
According to the most recent data available, 2019’s participating institutions collectively spent more than $6.6 billion in research, created 2,764 new inventions, secured 745 new U.S. patents, and launched 117 new startups in 2017 alone, according to the Association of University Technology Managers.
At the inaugural conference last year, 113 people attended the conference, including representatives from 24 companies and investment groups. About 146 one-on-one partnering meetings were scheduled over the two day conference.
Cost is $500 per ticket, but a limited number of registration fees will be waived for those who represent pharmaceutical firms, investment groups or other parties interested in supporting early-stage therapeutics. Contact conference organizers to learn how to receive a waiver code.